What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2014
Event60th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis - Milwaukee, United States
Duration: 23 Jun 201426 Jun 2014

Scientific committee

Scientific committee60th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis
CountryUnited States
CityMilwaukee
Period23/06/1426/06/14

Cite this

Douxfils, J., Baudar, J., Devalet, B., Samama, M. M., Chatelain, B., Dogne, J-M., & Mullier, F. (2014). What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?. Poster session presented at 60th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis, Milwaukee, United States.